Bristol Myers Squibb
Bristol Myers Squibb (BMY - Get Report) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. This stock is trading down 0.09% at $34.24 in recent trading after hitting a 52-week high of $34.50 earlier in the day.
Today's Range: $34.21-$34.5052-Week Range: $24.97-$34.50 Volume: 9.8 million Three-Month Average Volume: 13.3 million Bristol Myers Squibb has a market cap of $58.06 billion and an enterprise value of $55.50 billion. The stock trades at a trailing price-to-earnings of 17.67. The stock also trades at a price-to-sales of 2.78 and a price-to-book of 3.50. The current short interest as a percentage of the float for Bristol Myers Squibb is 1.7%. From a technical standpoint, BMY recently triggered a breakout trade after the stock cleared some past overhead resistance at $33.20 to $33.27 on decent volume. Market players should now stay with a long bias trading plan for BMY as long as the stock doesn't move back below those key breakout levels. Bristol-Myers was featured recently in " 7 Dividend Stocks Shoveling Cash to Shareholders."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts